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Beginning with the discovery of X rays in 1895, German
scientists and clinicians were instrumental in establishing
the fields of diagnostic and therapeutic radiology, creating
the first radiation therapy peer-reviewed journal, and
holding the first international oncologic conference. These
landmark achievements profoundly influenced the nascent
field of radiation oncology. However, the rapid early
scientific progress was halted by World War I, derailed
during World War II, and slowly reestablished amid the
divisions of the Cold War. Figure 1 chronicles many ra-
diation therapy milestones during these distinct periods.
Today, Germany has reemerged as a scientific leader in
the field of radiation therapy and a pioneer in radiobi-
ology research and clinical implementation of particle
therapy. Here we explore the technical advances and the
clinical evolution of radiation therapy in Germany from
the groundbreaking establishment of Bismarck’s health




open accEstablishment of the Bismarck Health Care
System
Otto von Bismarck, born in Scho¨nhausen of modern-day
Saxony-Anhalt in 1815, is considered the father of many
contemporary health care systems, including in his native
Germany (1). Perhaps best known for his political philos-
ophy Realpolitik, a pragmatic political system based on the
reality of circumstances rather than any specific ideology,
he held a pivotal role in the German unification of 1871,
which required the navigation of frequently harrowing po-
litical waters. On one hand, Bismarck was beholden to the
Prussian aristocracy, to whom he owed his position as
chancellor of the newly formed empire. On the other, the
socialist movement and liberal ideology of the time were
rapidly gaining influence in the mid-19th century during
which time Bismarck’s Prussian contemporary, Karl Marx,
wrote Manifest der kommunistischen Partei and Das
Kapital. Bismarck’s famed political strategy, including his
health care agenda, required the implementation of legis-
lation that would satisfy diametrically opposed forces (2).AcknowledgmentdThe authors thank Anthony Zietman, Katja Lindel,
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Otto von Bismarck becomes first chancellor of Germany (1871)
Accident Insurance Bill (1884)
Old Age & Disability Insurance Bill (1889)
Freund successfully treats hairy cell nevus (1896)
First German textbook on Radiotherapy published (1907)
First Congress of the DRG (1905)
Strahlentherapie is first published (1912)
Röntgen wins Nobel Prize in Physics (1901)
“On a New Kind of Rays” is published (1895)
Health Insurance Bill (1883)
First post-war DRG congress (1920)
CERN convention established (1953)
GSI founded (1969)
Tabak und Organismus is published (1939)
Marburg Ion-Beam Therapy Center opens (2015)
West German Proton Therapy Center (Essen) opens (2013)
DEGRO founded (1995)
GSI begins clinical use of heavy ion therapy (1997)
Heidelberg Ion-Beam Therapy Center &
Rinecker Proton Therapy Center (Munich) open (2009)
Bismarck & La Belle Époque
1871 - 1914






Fig. 1. Timeline of radiation therapy milestones in Germany.
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to adopt a program of Staatssozialismus, or state socialism.
The German legislature responded with the introduction of
three bills while Bismarck remained in power: the health
insurance bill of 1883, the accident insurance bill of 1884,
and the old age and disability insurance bill of 1889.
Whereas further welfare state projects would be imple-
mented following Bismarck’s fall from grace, these bills
represent the first major global foray into a regulated health
care system.
The Bismarck model, persisting 133 years since its
introduction, has evolved within its homeland and has been
propagated internationally. The Bismarck model mandates
universal health care through the creation of “sickness
funds”dessentially insurance policies funded jointly by
employer and employee. This model is unchanged at its
core today and represents the backbone with which modern
oncologic care is delivered in Germany. Its European rival
is the Beveridge model, a single-payer universal health care
system named after William Beveridge, the father of the
United Kingdom’s National Health Services (3).Fig. 2. “On a New Kind of Ray,” journal of the Wu¨rzburg
Physical-Medical Society, December 28, 1895.Wilhelm Conrad Ro¨ntgen’s Discovery of X Rays
In the 19th century, Germany was not merely an incubator
for social policy, which still dominates today’s medical
practice, but was also at the forefront of scientific discovery.
In late fall of 1895 at the University of Wu¨rzburg, Wilhelm
Conrad Ro¨ntgen unknowingly released X rays from cathode
ray tubes (4). These X rays struck nearby paper coated with
barium platinocyanide, causing it to “light up with brilliant
fluorescence” (5, 6). Ro¨ntgen hastily published his finding
in an article titled “U¨ber eine neue Art von Strahlen” (“On
a New Kind of Ray”) in the journal of the Wu¨rzburg
Physical-Medical Society on December 28, 1895 (Fig. 2)
(7). Ro¨ntgen’s wife, Anna Bertha Ludwig, when shown the
now iconic X ray image of her hand, famously remarked, “I
have seen my own death!” The image would be presented at
a meeting of the Berlin Physical Society a week later in
January, the first public display of the medical X ray. News
of his discovery, which due to of their peculiarity he named
X rays “for the sake of brevity,” propagated widelythroughout the industrial world, culminating with a New
York Times article on January 12, 1896 proclaiming “Hid-
den Solids Revealed!” (8).
A wildly productive period in the novel field of radi-
ation physics followed, with the discovery of radioac-
tivity by Henri Becquerel in France in 1896 and the
electron by J. J. Thompson in England in 1897 (6).
Although there is some controversy regarding the first
therapeutic use of X rays, the successful treatment in
Vienna of a giant hairy cell nevus by Leopold Freund in
November 1886 is one of the first documented in the
literature (9). Emerging evidence suggest that in the
French city of Lyon the first oncologic application of
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treated a neighbor with what was likely gastric lym-
phoma in July 1896 (10). In the Lyon Medical Journal,
Despeignes detailed a vivid description of this patient’s
remarkable clinical response, concluding, “.dealing
with a less advanced and less rapid cancerous affliction,
we might not have the hope, if not of a cure, at least,
of a prolonged survival by using the treatment that we
have inaugurated.” Oncologic applications were far
from the only pursuits, inasmuch as explorations into
therapeutic radiation were wide-ranging and were adop-
ted enthusiastically, including in the treatment of
tuberculosis.
The early years of the 20th century were remarkably
productive, punctuated by the founding of the Deutsche
Ro¨ntgengesellschaft (German Ro¨ntgen Society, DRG) in
1905 and the founding of the Institut fu¨r Experimentelle
Krebsforschung (Institute for Experimental Cancer
Research) in 1906, a predecessor of the modern Deutsches
Krebsforschungszentrum (German Cancer Research Cen-
ter) (11). The Institute for Experimental Cancer Research
founder was Vincenz Czerny, a professor of surgery and a
pioneer in multidisciplinary oncologic treatment (Fig. 3).
Contributions from multiple German natives helped propel
the nascent field internationally with the publication of the
first German radiation therapy textbook in 1907 and the
world’s first radiation oncology journal, Strahlentherapie,Fig. 3. Vinzenz Czerny (1842-1916) surgeon and founder
of the Institute for Experimental Cancer Research.published in 1912. Figure 4A illustrates a typical radiation
therapy treatment room in Heidelberg, circa 1912, and is
juxtaposed with a modern treatment room at the Heidelberg
Ion Beam Therapy Center (Fig. 4B). In the prewar era,
Germany not only was responsible for critical de-
velopments in radiology and radiation therapy but was a
driving force in the international cancer research
community.Turbulence and Tragedy of World Wars I and II
The tremendous scientific leaps observed during La Belle
E´poqueda period of Western European prosperity between
1871 and 1914 that produced many technical and cultural
innovationsdcame to an abrupt halt in Germany on June
28, 1914 when the assassination of Archduke Franz Fer-
dinand ushered in the Great War and effectively severed
German radiologists from the international scientific com-
munity. During World War I, all DRG congresses ceased.
With the exception of a few scattered radiologic publica-
tions, very little is known about radiologic research during
this period, and no DRG archives exist. The first postwar
DRG congress occurred in 1920, and fierce debate revolved
around the establishment of radiology as an independent
specialty or fragmentation of the specialty into specific
wings within surgery and internal medicine (11). This
debate would rage on for several more decades despite
radiology’s independence elsewhere in Europe and the
United States, prompting the Swiss radiologist Hans Schinz
of the Ro¨ntgeninstitut of the University of Zu¨rich to
remark, “Germany, Ro¨ntgen’s homeland, has curiously
dropped behind.” At the same time, questions began to arise
regarding the fundamental concept of fractionation. The
German school of thought was to deliver massive toxic
doses of radiation over a minimal number of treatment
fractions, but morbid late effects and poor tumor control led
to unease in the radiology community, and the French
model of fractionation would ultimately spread throughout
Europe (4).
The early 1930s heralded a tumultuous and tragic era
with the rise of the Nazi regime. The insidious infiltration
of the Nazi state into the scientific community, termed
Gleichschaltung, or Nazification, resulted in the neutrali-
zation of political dissidents by either death or emigration.
The DRG became completely regulated by the Nazi state,
beginning with the removal of DRG president and political
dissident Robert Kienbock (11). In the famed Charite´
Hospital in Berlin, home of the renowned pathologist
Rudolf Virchow, many cancer researchers were expelled
because of their Jewish heritage. In 1933, the Nazi sterili-
zation law was enacted and was implemented surgically or
with the use of X rays, emboldening the proponents of
eugenics with proposals of sterilization for selected cases of
hereditary disease. This brutality peaked in Auschwitz,
where sterilization of entire ethnic groups was undertaken,
and by the end of the war 350,000 people had been
Fig. 4. (A) Radiation treatment room in the Institute for Experimental Cancer Research, ca 1912. (B) Modern radiation
treatment room at the Heidelberg Ion Beam Therapy Center.
Lischalk et al. International Journal of Radiation Oncology  Biology  Physics732sterilized (12). The German medical community, which
before the 1940s had boasted half of the world’s Nobel
Prizes and a large portion of the world’s patents, was
decimated by the Third Reich.
Equally disturbing and even more difficult to reconcile
are the scientific initiatives fostered under Nazi fascism.
The question became, as Stanford scientific historian
Robert N. Proctor states, “What is this science that was
allowed to flourish under fascism?” (12). In 1928, cancer
surpassed tuberculosis as the second most common cause
of death in Germany and was declared “the number one
enemy of the state,” thus becoming a focus of the rising
Third Reich. Inherent within Nazi rhetoric were sordid,
hyperracialized genetic theories, which existed as propa-
ganda to further the regime’s demographic prejudices. With
the German scientific community in disarray, basic scienceresearch faltered. However, owing to the strict authoritarian
Nazi hold on the country, aggressive public health initia-
tives were undertaken. In 1938, an intense propaganda
machine for the early identification of colon, breast, and
gynecologic cancer was waged, which was accompanied by
the creation of a widespread German Cancer Registry
focused on incidence and pathology (12). This Third Reich
obsession with cancer population statistics must be inter-
preted with caution in light of the potential for abuse of
such demographic data.
Antithetically, in this repressive Nazi era an open war
was waged on the tobacco industry with an aggressive
antitobacco campaign in the 1940s, which included public
health outreach and education, advertising bans, and re-
strictions on public smoking. Much of this antitobacco
fervor began with Fritz Lickint, who released epidemiologic
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lished Tabak und Organismus in 1939, and became known
as the physician “most hated by the tobacco industry” (12).
Furthermore, other health initiatives were enacted to limit
occupational hazards to asbestos, chromate, and aromatic
amines, although foreigners and those of “undesirable de-
mographics” were exempt from these safeguards. The chief
physician of the German Labor Front, Hermann Hebestreit,
also demonstrated a link between lung cancer and radium
exposure in Joachimstal uranium miners in 1939 (12).
During this period, rigorous radiation exposure regulations
were enacted. Interestingly, these radiation safety initiatives
were propelled forward by eugenicists, who fought with
socialists who scoffed at the dangers of excessive radiation.
Although progressive cancer preventative and management
strategies were implemented for the “desirable” population,
these same methods were ignored or used against those who
were deemed enemies of the Nazi regime.Cold War Divisions
Unconditional surrender on May 8, 1945, ended the efforts
of the Third Reich, although the subsequent Allied occu-
pation and fragmentation of Germany into East (German
Democratic Republic) and West (Federal Republic of
Germany) brought about new challenges. During this
period, American, Scandinavian, and British scientific ad-
vances vastly outpaced those in Germany. Some of these
foreign advances in radiation therapy were adopted in West
Germany, yet in the German Democratic Republic USSR-
enforced restrictions suffocated radiation therapy progress.
Owing to economic restrictions imposed by the Soviet
Council for Mutual Economic Assistance, the production of
top-tier cobalt units in Dresden was abandoned in favor of
construction of radiation therapy equipment in Czechoslo-
vakia (11). These machines were of such poor quality that
East German physicians were forced to import a handful of
foreign units at high cost. In West Germany, scientific
progress carried on, including the development of inverse
treatment planning system optimization algorithms by
German physicists Wilfgang Schlegel and Thomas Bortfeld
of the DKFZ, to be used a decade later for intensity
modulated radiation therapy (13).
Huge scientific leaps were also made in the field of
particle physics. In 1953 the Conseil Europe´en pour la
Recherche Nucle´aire (CERN) convention was established
and included West Germany as one of the founding mem-
ber states (14). The Gesellschaft fu¨r Schwerionenforschung
(GSI) was created in Darmstadt, West Germany, in 1969
and would become a center that established Germany as a
leader in the clinical application of heavy ion therapy.
Gerhard Kraft can be credited as the forefather of the
modern ion therapy movement in Germany. Kraft was
trained as a nuclear physicist and radiobiologist, and after
graduating from the University of Cologne, he completed a
fellowship at the Lawrence Berkeley Laboratory under thesupervision of Cornelius Tobias. In 1981 he returned to
Germany as a staff member at the GSI and introduced
particle therapy to Europe. Kraft became the founder and
director of the Biophysics Department at the GSI and
eventually proposed a pilot project for the clinical use of
ion therapy. This plan was implemented as a joint initiative
of Heidelberg University Hospital, DKFZ, and GSI.
Translation of basic science to clinical treatment at the GSI
occurred in 1997, when the first patient was treated with
carbon ions for a chordoma. From 1997 to 2008, more than
400 patients were treated with ion therapy at the GSI (14).
In November 1989, the fall of the BerlinWall heralded the
most productive scientific era in Germany sinceWorldWar I,
although the turbulent reunification led to marginalization of
some East German physicians. In fact, many lost their posi-
tions in favor of often younger or less qualified West German
doctors (11). In addition, a well-established East German
cancer registry was disbanded by the West. Nevertheless,
significant investments were made to improve the obsolete
equipment inEastGermany, andmany subsidies continue into
the modern era. In November 1995, the German Society of
Radiation Oncology (DEGRO) was founded, led by its first
president, Michael Bamberg, and so began the modern era of
radiation oncology in Germany (11).
Modern Radiation Oncology in Germany
Health care system and structure
Bismarck’s vision in the late 1800s has evolved into a shared
German understanding of the fundamental pillars of health
care: affordability, accessibility, and quality. The principle
of solidarity, or Solidarita¨tsprinzip, of the health care sys-
tem has survived world wars, political revolutions, and
numerous health care and social reforms. Eighty-nine
percent of the population pays into the community-based
sickness funds, or Gesetzliche Krankenversicherung
(GKV). Up to a certain income level, membership to the
GKVs is obligatory, whereas residents with higher incomes
and the self-employed may contribute as voluntary mem-
bers. The remaining population uses private health insur-
ance, thus ensuring complete coverage of the German
population (15). Financing of the sickness funds is accom-
plished by shared employee and employer contributions
totaling 14.6% of wages (16). Interestingly, services paid for
by the GKVs must be defined as “necessary,” with a
scientifically proven benefit, and the costs must be deemed
“reasonable” in relation to that potential benefit. This ability
to tie reimbursement with assurance of standard-of-care
delivery at an appropriate price is a paramount achieve-
ment, and continues to be sought after in the United States.
Medical education and radiation oncology training
Medical education in Germany dates back to 1386 with the
establishment of Heidelberg University. Along with law,
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ing schools at Heidelberg. Germany’s universities are in
large part public institutions, with affordable tuition rates of
approximately V60 per semester, ensuring accessible sec-
ondary education for the general public. Many independent
entities, such as the Helmholtz Alliance and the Max-
Planck Institute, also exist as autonomous nonprofit
research organizations with loose cooperative affiliations
with academic universities throughout Germany.
Medical education is highly competitive, with a limited
number of positions; thus, many prospective students wait
several years before acceptance. Studies are generally held
in German, although English is used regularly as a conse-
quence of standards in the international literature. In fact,
English language education often begins in preschools,
with mandated proficiency of at least one foreign language
for university acceptance. Medical school consists of two
preclinical years (Vorklinik), three clinical years (Klinik),
and one practical year (Praktisches Jahr), each requiring
satisfactory completion of a written or oral exam before
advancement, culminating in a license to practice medicine
in Germany (Approbation). To receive the academic degree
Dr. med. (Doctor of Medicine), which is not mandatory, a
candidate must additionally complete a scientific study and
dissertation, either during medical school or after
graduation.
After completion of medical school, physicians wishing
to specialize in radiation oncology complete five additional
years of training in academic hospitals to meet the eligi-
bility requirements for specialist education. The application
process for residency is free of charge and is not strictly
regulated on a national level as is the match process in the
United States. Encapsulated within radiation oncology
training is a 12-month rotation through hospital wards. The
ward experience is often specific to inpatient oncologic care
and is taught in conjunction with medical oncology. As
such, residents gain experience with the delivery and
management of chemotherapy and are certified to deliver
care independently at the completion of training. An
additional 12 months may be completed in diagnostic
radiology, although this is no longer required. In contrast to
the United States, graduation from training does not come
with a massive increase in salary, although this difference is
offset in part by the virtually negligible student loans
accumulated during training in Germany. Overall, 90% of
German radiation oncology trainees have stated that they
were very pleased with their decision to enter the field (17).Fig. 5. Heavy ion gantry at the Heidelberg Ion Beam
Therapy Center.Particle therapy development
In an effort to expand the clinical application of particle
therapy initiated at the GSI, the Heidelberg Ion Beam
Therapy Center (HIT) opened in 2009 as a joint endeavor
of the GSI and Siemens Medical Company (14). The HIT
allows for clinical treatment with both proton and carbon
ions, with future capabilities for helium and oxygentreatment. The HIT contains the world’s first heavy ion
gantry, housed in three stories and weighing over 600 tons
(Fig. 5). It is one of only a handful of centers worldwide
(Germany, Japan, Italy, and China) with the ability to treat
patients with carbon therapy. Treatment with heavy ions
has traditionally been reserved for radioresistant and locally
aggressive tumors such as chordomas, chondrosarcomas,
and adenoid cystic carcinomas or complex reirradiation
cases. Under the direction of Ju¨rgen Debus, more than 3600
patients have been treated at the HIT since 2009. New in-
novations including the active raster scanning technique,
where particles are magnetically guided over the target
volume and modulated in intensity, were developed at the
GSI and implemented at the HIT (18). Additionally, the
development of a quantitative calculation of relative bio-
logic effects (RBE) using the theoretic local effect model
(LEM) was established at the GSI, which allows for opti-
mization of treatment planning according to biologic pa-
rameters and is regularly implemented for HIT treatment
plans (19). Five additional proton centers are in clinical
operation within Germany and include the Rinecker Proton
Therapy Centre (Munich, 2009), the West German Proton
Therapy Center (University Hospital Essen, 2013), the Ion
Beam Laboratory at the Hahn-Meitner-Institute (Charite´
University Hospital Berlin, 1998), the Proton Therapy
Center (University Hospital Dresden, 2014), and the Mar-
burg Ion Beam Therapy Center (Marburg, 2015).
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As particle therapy advances and accessibility expands,
many of the same challenges found in the United States
have manifested themselves in Germany. Although most
radiation oncologists would agree that the physical dose
distribution and perhaps the radiobiologic effect of protons
is superior to that of photons, clinical data have yet to
establish proton superiority. The substantial investments,
particularly for carbon ion therapy, and the higher costs per
treatment are currently not sufficiently justified by clinical
data, particularly in view of the lack of direct comparisons
with photon therapy in the phase 3 setting. However, in
Germany the potential benefit of treatment with particle
therapy for certain tumor types, including chordomas,
chondrosarcomas, arteriovenous malformations, uveal tu-
mors, adenoid cystic carcinomas, and pediatric malig-
nancies, has been accepted by the GKV thus making full
reimbursement ubiquitous.
Clinical implementation of carbon ion therapy is a
rapidly expanding area of investigation with approxi-
mately 20 accruing phase 1 and 2 trials and two ran-
domized phase 3 trials at the HIT. In addition, research
into the application of helium and oxygen is currently
focused at preclinical physics and radiobiological levels.
Finally, investigation into advanced modalities of image
guided radiation therapy prompted the German Research
Foundation in 2016 to subsidize the commissioning of
two magnetic resonance imagingdguided radiation ther-
apy units at Tu¨bingen University Hospital and Heidelberg
University Hospital.
Conclusion
From the moment the first aberrant photons were revealed
in Wu¨rzburg, the evolution of radiation oncology in
Germany has taken the form of a medical Bildungsroman,
undulating with the sociopolitical changes and challenges
of the time. Germany now enters a new phase of scientific
and medical exploration, although this era is not without its
own challenges. Rising German health care expenditures,
the fragility of the European Union, and a massive influx ofimmigrants promise to alter the dynamic of the German
medical landscape for years to come.References
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